Quantum Biopharma (QNTM) Operating Expenses (2019 - 2026)

Quantum Biopharma's Operating Expenses history runs 8 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 12.69% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $14.9 million (up 11.88% YoY), while the FY2025 annual figure was $15.3 million, down 5.17% from the prior year.
• Operating Expenses came in at $3.0 million for Q1 2026 at Quantum Biopharma, up from $2.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $9.8 million in Q1 2023 to a low of $1.9 million in Q2 2023.
• A 5-year average of $3.9 million and a median of $3.4 million in 2025 frame the typical range for Operating Expenses.
• On a YoY basis, Operating Expenses climbed as much as 84.77% in 2024 and fell as far as 77.07% in 2024.
• Quantum Biopharma's Operating Expenses stood at $5.6 million in 2022, then tumbled by 41.38% to $3.3 million in 2023, then sank by 31.84% to $2.3 million in 2024, then rose by 5.14% to $2.4 million in 2025, then increased by 24.98% to $3.0 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $3.0 million, $2.4 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison